Felix Kleefeld

412 total citations
25 papers, 181 citations indexed

About

Felix Kleefeld is a scholar working on Molecular Biology, Epidemiology and Neurology. According to data from OpenAlex, Felix Kleefeld has authored 25 papers receiving a total of 181 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Epidemiology and 5 papers in Neurology. Recurrent topics in Felix Kleefeld's work include Inflammatory Myopathies and Dermatomyositis (10 papers), Muscle Physiology and Disorders (5 papers) and Genetic Neurodegenerative Diseases (4 papers). Felix Kleefeld is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (10 papers), Muscle Physiology and Disorders (5 papers) and Genetic Neurodegenerative Diseases (4 papers). Felix Kleefeld collaborates with scholars based in Germany, Denmark and United Kingdom. Felix Kleefeld's co-authors include Katrin Hahn, Werner Stenzel, Corinna Preuße, Antje Kraft, Patrick Ingiliz, Heiko Jessen, Tobias Ruck, Christopher Nelke, Udo Schneider and Andreas Roos and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Scientific Reports.

In The Last Decade

Felix Kleefeld

21 papers receiving 178 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Felix Kleefeld Germany 9 105 77 28 23 22 25 181
Eiji Ehara Japan 9 86 0.8× 126 1.6× 15 0.5× 9 0.4× 11 0.5× 26 265
Francesco Saettini Italy 9 21 0.2× 46 0.6× 14 0.5× 6 0.3× 8 0.4× 31 214
Alison Boyd Australia 10 61 0.6× 171 2.2× 34 1.2× 6 0.3× 23 1.0× 22 326
L. Sfaihi Tunisia 7 28 0.3× 62 0.8× 4 0.1× 8 0.3× 13 0.6× 42 199
Natalia Basantsova Russia 8 53 0.5× 30 0.4× 2 0.1× 10 0.4× 39 1.8× 13 294
Charlotte Laurent France 7 29 0.3× 32 0.4× 6 0.2× 16 0.7× 95 4.3× 15 208
Cristina Verdejo Spain 10 66 0.6× 50 0.6× 3 0.1× 17 0.7× 3 0.1× 13 253
Marta Pascual Spain 6 146 1.4× 20 0.3× 2 0.1× 112 4.9× 14 0.6× 10 244
Lina Jiang China 8 52 0.5× 63 0.8× 35 1.3× 11 0.5× 49 2.2× 15 271
Madlen Löbel Germany 8 41 0.4× 55 0.7× 2 0.1× 16 0.7× 26 1.2× 11 206

Countries citing papers authored by Felix Kleefeld

Since Specialization
Citations

This map shows the geographic impact of Felix Kleefeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felix Kleefeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felix Kleefeld more than expected).

Fields of papers citing papers by Felix Kleefeld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Felix Kleefeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felix Kleefeld. The network helps show where Felix Kleefeld may publish in the future.

Co-authorship network of co-authors of Felix Kleefeld

This figure shows the co-authorship network connecting the top 25 collaborators of Felix Kleefeld. A scholar is included among the top collaborators of Felix Kleefeld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Felix Kleefeld. Felix Kleefeld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ruck, Tobias, et al.. (2025). Inclusion body myositis – what are new lines of pathogenesis and therapy?. Current Opinion in Neurology. 38(5). 546–550.
2.
Falzone, Yuri, Marco Ceccanti, Felix Kleefeld, et al.. (2025). Mitochondrial pathology in inflammatory myopathies: a marker of worse clinical outcome. Journal of Neurology. 272(7). 480–480. 1 indexed citations
3.
4.
Ruffer, Nikolas, Felix Kleefeld, Martin Krusche, et al.. (2024). Vaskulitische Beteiligung der Skelettmuskulatur und des peripheren Nervensystems: Klinische und neuropathologische Perspektive. Zeitschrift für Rheumatologie. 84(3). 210–218.
5.
6.
Kleefeld, Felix, Rita Horváth, Iago Pinal‐Fernandez, et al.. (2024). Multi-level profiling unravels mitochondrial dysfunction in myotonic dystrophy type 2. Acta Neuropathologica. 147(1). 19–19. 6 indexed citations
7.
Nelke, Christopher, Simone Schmid, Felix Kleefeld, et al.. (2024). Complement and MHC patterns can provide the diagnostic framework for inflammatory neuromuscular diseases. Acta Neuropathologica. 147(1). 15–15. 13 indexed citations
8.
Hentschel, Andreas, Felix Kleefeld, Christopher Nelke, et al.. (2024). Molecular composition of skeletal muscle in infants and adults: a comparative proteomic and transcriptomic study. Scientific Reports. 14(1). 22965–22965. 2 indexed citations
9.
Schroeter, Christina B., Corinna Preuße, Marc Pawlitzki, et al.. (2023). Senescent fibro-adipogenic progenitors are potential drivers of pathology in inclusion body myositis. Acta Neuropathologica. 146(5). 725–745. 19 indexed citations
10.
Kleefeld, Felix, Andreas Hentschel, Arpad von Moers, et al.. (2023). Beyond vacuolar pathology: Multiomic profiling of Danon disease reveals dysfunctional mitochondrial homeostasis. Neuropathology and Applied Neurobiology. 49(4). e12920–e12920. 3 indexed citations
11.
Kleefeld, Felix & Benedikt Schoser. (2023). The current clinical perception of myotonic dystrophy type 2. Current Opinion in Neurology. 36(5). 474–478. 3 indexed citations
12.
Kleefeld, Felix, Corinna Preuße, Gabriele Arendt, et al.. (2023). Morphological and molecular comparison of HIV-associated and sporadic inclusion body myositis. Journal of Neurology. 270(9). 4434–4443. 2 indexed citations
13.
Nelke, Christopher, Felix Kleefeld, Corinna Preuße, Tobias Ruck, & Werner Stenzel. (2022). Inclusion body myositis and associated diseases: an argument for shared immune pathologies. Acta Neuropathologica Communications. 10(1). 84–84. 14 indexed citations
14.
Schneider, Udo, Elise Siegert, Felix Kleefeld, et al.. (2021). Performance of ENMC and EULAR/ACR classification systems applied to a single tertiary center cohort of dermatomyositis patients. SHILAP Revista de lepidopterología. 3(1). 59–59. 3 indexed citations
15.
Siegert, Elise, Akinori Uruha, Hans‐Hilmar Goebel, et al.. (2021). Systemic sclerosis-associated myositis features minimal inflammation and characteristic capillary pathology. Acta Neuropathologica. 141(6). 917–927. 23 indexed citations
16.
Schatka, Imke, Alexander Berger, Burkert Pieske, et al.. (2020). Isolated Atrial Amyloidosis Suspected by Electrophysiological Voltage Mapping and Diagnosed by 99mTc-DPD Scintigraphy. ESC Heart Failure. 7(6). 4305–4310. 2 indexed citations
17.
Kleefeld, Felix, Gabriele Arendt, Eva Neuen-Jacob, et al.. (2020). Neurologische Komplikationen der Hepatitis-C-Infektion. Der Nervenarzt. 92(2). 144–149. 1 indexed citations
18.
Kleefeld, Felix, Fabian Knebel, Dennis Eurich, et al.. (2020). Familial Oculo-Leptomeningeal Transthyretin Amyloidosis Caused by Leu55Arg Mutation. Journal of Neuromuscular Diseases. 7(4). 515–519. 5 indexed citations
19.
Kleefeld, Felix, Patrick Ingiliz, Heiko Jessen, et al.. (2018). Interferon-free therapy in hepatitis C virus (HCV) monoinfected and HCV/HIV coinfected patients: effect on cognitive function, fatigue, and mental health. Journal of NeuroVirology. 24(5). 557–569. 26 indexed citations
20.
Holzinger, Felix, et al.. (2017). Discharge management strategies and post-discharge care interventions for depression – Systematic review and meta-analysis. Journal of Affective Disorders. 223. 82–94. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eiji Ehara Breakdown of academic impact, for papers by Francesco Saettini Breakdown of academic impact, for papers by Alison Boyd Breakdown of academic impact, for papers by L. Sfaihi Breakdown of academic impact, for papers by Natalia Basantsova Breakdown of academic impact, for papers by Charlotte Laurent Breakdown of academic impact, for papers by Cristina Verdejo Breakdown of academic impact, for papers by Marta Pascual Breakdown of academic impact, for papers by Lina Jiang Breakdown of academic impact, for papers by Madlen Löbel
Rankless by CCL
2026